Ocugen Company
Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Technology:
Others
Industry:
Gene Therapy
Headquarters:
Malvern, Pennsylvania, United States
Founded Date:
2013
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
2
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership